Press "Enter" to skip to content

Merck’s stock rallies toward a record after FDA OKs arterial-hypertension drug

https://www.marketwatch.com/story/mercks-stock-rallies-toward-a-record-after-fda-oks-arterial-hypertension-drug-d2259422?mod=mw_rss_topstories
Merck’s stock rallied into record territory Wednesday, after the drug giant’s treatment for pulmonary arterial hypertension, Winrevair, was approved by the U.S. Food and Drug Administration…

More from BusinessMore posts in Business »
More from UncategorizedMore posts in Uncategorized »